Dr. Syed A. Abutalib earned his medical degree from Dow Medical College in Karachi, Pakistan. PHAGE: Therapy, Applications, and Research is the only peer-reviewed journal dedicated to fundamental bacteriophage research and its applications in medicine, agriculture, aquaculture, veterinary applications, animal production, food safety, and food production. Molecular Therapy is the monthly publication of the American Society of Gene Therapy (ASGT). Dr. Handgretinger's main research interests are cellular immunotherapeutic approaches to the treatment of children and adults with various forms of cancer. Stem Cell Research & Therapy Impact Factor, IF, number of article, detailed information and journal factor. News. The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef. If you do not receive an email within 10 minutes, your email address may not be registered, The cover image © Atara Biotherapeutics, Inc. is based on the Original Article, Towards “off-the-shelf” allogeneic CAR T cells by Blake Aftab et al., The cover image is based on the Invited Review. and you may need to create a new Wiley Online Library account. All articles include a section or feature detailing the current and future clinical implications of the research. Learn about our remote access options, Edited By: Syed A. Abutalib & Rupert Handgretinger. The Journal has an extensive, internationally renowned Editorial team, consisting of experts within the field of cell and gene therapy who work alongside the Editors-in-Chief. Over the past decade, gene therapy has enabled curative outcomes in previously untreatable genetic diseases such as X-linked severe combined immunodeficiency. Enter your email address below and we will send you your username, If the address matches an existing account you will receive an email with instructions to retrieve your username. Director, Stem Cell Transplantation Consultant Haematologist, St George's Hospital and Medical School London, UK Program and Medical Director Cell Therapy Facility, Blood Services Group Health Sciences Authority Singapore Gene therapy development for hemophilia B preceded that of hemophilia A, as the factor IX gene was smaller in size and easier to fit into AAV vectors than was the factor VIII gene . Please check your email for instructions on resetting your password. The Journal Impact 2019-2020 of Advances in Cell and Gene Therapy is still under caculation. Dr. Rupert Handgretinger earned his medical degree from the University of Tübingen, Germany. The impact factor of Molecular Therapy, ASGCT’s first and primary journal, rose 19.9 percent to 8.402 and remains the top journal in the field. Working off-campus? In 2010, Dr. Handgretinger was appointed the Medical Director of the Children's University Hospital in Tübingen. Given the rapid positive advances in the field of cell and gene therapies and the explosive growth of immunotherapy for nonmalignant and neoplastic disorders, the journal's content will be useful for readers worldwide. Dr. Abutalib continues to collaborate with other experts worldwide in the area of hematology/oncology and transplantation to explore and develop innovative ideas and breakthroughs in Medical Education with a primary focus on improvement of patient care. Please check your email for instructions on resetting your password. Impact factors, which measure the frequency with which an average article has been cited in a journal, rank research titles against one another to determine leading journals around the world. Please visit the journal's Aims & Scope and Author Guidelines pages for further information. Faktor Dampak 2019 dari Advances in Cell and Gene Therapy masih dalam perhitungan. The Journal Impact Quartile of Advances in Cell and Gene Therapy is still under caculation.The Journal Impact of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. Each year research scientists have noticed a rise in the number of congresses being held in this field. The topics the journal covers include hematopoietic cell transplants and cell, gene and immune therapies in children and adults with a wide range of disorders, including cancers, genetic and immune diseases. ISSN: 1757-6512. Working off-campus? Learn about our remote access options, Syed Abutalib MDFounding Editor and Editor-in-Chief, Assistant DirectorStem Cell Transplant & Cell Therapy ProgramMedical DirectorApheresis Collection FacilityHematologist and Medical OncologistMidwestern Regional Medical CenterChicago, USA, Full Professor of Pediatrics, ChairChildren's University Hospital and Department of Hematology and OncologyUniversity Hospital TubingenTubingen, Germany, The Joe Shapiro Professor of MedicineDivision of Oncology & HematologyUniversity of Nebraska Medical CenterNebraska, USA, Professor of MedicineFred Hutchinson Cancer Research CenterWashington, USA, Professor of Hematology, Clinical Immunology, OncologyLudwig-Maximilians University of MunichMunich, Germany, Director, Transfusion Medicine and Cellular TherapyProfessor of Pathology & Cell BiologyColumbia University Medical CenterNew York, USA, Abteilung für Gen-ImmuntherapieRCI Stiftung Regensburger Centrum für Interventionelle ImmunologieUniversitätsklinikum RegensburgRegensburg, Germany, Associate Professor of Institute of Health and EquityDivision of BiostatisticsMedical College of WisconsinWisconsin, USA, Ospedale Policlinico San MartinoIstituto di Ricerca a Carattere Scientifico per l'OncologiaGenova, Italy, Attending PhysicianBlood and Marrow Transplant ProgramThe Ottawa HospitalOttawa, Canada, Professor of HematologyUniversity of AntwerpMedical DirectorCenter for Cell Therapy and Regenerative MedicineAntwerp University HospitalAntwerp, Belgium, Chief of Service; Stem Cell Transplant and Cellular TherapiesPediatricsMemorial Sloan Kettering Cancer CenterNew York, USA, Medical OncologistDirector, Cellular TherapeuticsMemorial Sloan Kettering Cancer CenterNew York, USA, Associate Professor, MedicineHarvard Medical SchoolDirector, CLL CenterDana-Farber Cancer InstituteMassachusetts, USA, Assistant ProfessorPediatric Hematology, Oncology & BMTUniversity of WisconsinWisconsin, USA, Head of UnitHematology and Hematopoietic Stem Cell TransplantationOspedale San RaffaeleMilan, Italy, Associate ProfessorDepartment of Stem Cell TransplantationDivision of Cancer MedicineUniversity of TexasMD, Anderson Cancer CenterTexas, USA, Associate ProfessorDepartment of Medicine and UAB-CCCBone Marrow Transplantation and Cell Therapy ProgramUAB School of MedicineAlabama, USA, Director, BMT ProgramHuntsman Cancer CenterUniversity of UtahUtah, USA, Professor of Regenerative and Haematological MedicineKings CollegeLondon, UK, Director Stem Cell Transplant ProgramProfessor of Medicine, Case Western Reserve UniversitySeidman Cancer Center/University Hospitals Cleveland Medical Center, Assistant ProfessorHematologic Malignancies and Cellular TherapeuticsKU Medical CenterUniversity of KansasKansas, USA, Professor of MedicineDirector of the Lymphoma ProgramCo-Director of the Microbial Oncology ProgramDivision of Hematology & OncologyGWU Cancer CenterWashington, D.C., USA, Marcelo Fernandez Vina PhD, D (ABHI)Editorial Board, Professor of PathologyDirector of Histocompatibility, Immunogenetics & Disease Profiling LaboratoryStanford University School of MedicineCalifornia, USA, Investigator, Pediatric Oncology BranchCenter for Cancer ResearchNational Cancer InstituteMaryland, USA, Department of HematologyOsaka International Cancer InstituteOsaka, Japan, Robert Peter Gale MD, PhD, FACPEditorial Board, Visiting ProfessorHaematology Research CentreDivision of Experimental MedicineImperial College LondonLondon, UK, Director, Clinical Applications LaboratoryCenter for Cell and Gene TherapyTexas Children's HospitalTexas, USA, DirectorCase Comprehensive Cancer CenterOhio, USA, ProfessorDepartment of Cellular Biotechnologies and HematologyUniversity of Rome SapienzaRome, Italy, Head of the Division of HematologyMedicial University of GrazGraz, Austria, Novotny Professor of PediatricsUniversity of Pennsylvania Perelman School of MedicineSection Chief, Cellular Therapy and TransplantDirector, Cancer Immunotherapy Frontier ProgramDirector of Translational ResearchChildren's Hospital of PhiladelphiaPennsylvania, USA, Assistant Professor, Department of MedicineDivision of Hematology & OncologyHematology and BMTUniversity of Wisconsin Hospital and ClinicsWisconsin, USA, Associate Professor of MedicineAssistant Director, CIBMTRDivision of Hematology & OncologyMedical College of WisconsinWisconsin, USA, Parameswaran Hari MD, MRCPEditorial Board, Armand Quick - William Stapp Professor of HematologyInterim Chief, Division of Hematology and OncologyDirector, Adult Blood and Marrow Transplant ProgramMedical College of WisconsinWisconsin, USA, Public Health and General Preventive Medicine SpecialistHematologist, Bone Marrow Transplant ProgramMayo ClinicArizona, USA, Assistant ProfessorDepartment of Hematology/Hematopoietic Cell TransplantationCity of Hope Medical CenterCalifornia, USA, Professor of Medicine, Pediatrics, Surgery and Biomedical EngineeringDirector, Clinical Hematopoietic Cell Processing LaboratoryUniversity of Wisconsin-Madison School of Medicine and Public HealthWisconsin, USA, Geoff Hill MBChB, MD, BHB, FRCPA, FRACPEditorial Board, NHMRC Senior Principal Research FellowQLD Health Senior Clinical Research FellowCoordinator, Cancer Program, QIMR BerghoferClinical Director, Qgen, Bone Marrow Transplant LaboratoryQIMR Berghofer Research InstituteBrisbane, Australia, Professor of Medicine and HematologyPeking University People's HospitalPeking University Institute of HematologyBeijing, China, Max Eder Research GroupCAR T-cell Engineering Extraordinary MemberBavarian Academy of ScienceUniversity of WurzburgWurzburg, Germany, Professor of Medicine, Division of HematologyDirector, Chulabhorn Bone Marrow Transplant CenterDirector, Siriraj Center of Excellence for Stem Cell ResearchDepartment of Medicine, Faculty of MedicineSiriraj Hospital, Mahidol UniversityBangkok, Thailand, Professor, Department of Stem Cell TransplantationDivision of Cancer MedicineThe University of TexasAnderson Cancer CenterTexas, USA, Mickey Koh MD, PhD, FRCP, FRCPathEditorial Board, Director, Stem Cell TransplantationConsultant Haematologist, St George's Hospital and Medical SchoolLondon, UKProgram and Medical DirectorCell Therapy Facility, Blood Services GroupHealth Sciences AuthoritySingapore, Medical Director, Department of Stem Cell TransplantationUniversity Hospital Hamburg-EppendorfHamburg, Germany, Chief Scientific OfficerRobertson Clinical and Translational Cell Therapy ProgramDirector, Pediatric Blood and Marrow Transplant ProgramDuke UniversityNorth Carolina, USA, Professor of MedicineChief, Myeloma ServiceMemorial Sloan Kettering Cancer CenterNew York, USA, Research Assistant ProfessorHematology and OncologyUniversity of FloridaFlorida, USA, Full Professor of PediatricsUniversity of PaviaDirector, Department of Pediatric Hematology and OncologyIRCCSRome, Italy, Associate Professor of MedicineDirector, Clinical Stem Cell LaboratoryUI Blood & Marrow Transplantation ProgramUniversity of IllinoisIllinois, USA, Blood and Marrow Transplant ProgramCleveland ClinicOhio, USA, Assistant ProfessorPediatrics, Division of Cellular and Molecular TherapyUniversity of FloridaFlorida, USA, Department of Hematopoietic Stem Cell TransplantationFederal Research Center for Pediatric Hematology, Oncology and ImmunologyMoscow, Russia, Assistant Professor, MedicineHarvard Medical SchoolDirector of Cellular ImmunotherapyCancer CenterMassachusetts General HospitalMassachusetts, USA, Medical DirectorAdult Blood and Marrow Stem Cell Transplant & Cellular Therapy ProgramProfessor of MedicineOregon Health and Science UniversityOregon, USA, Chair, Division of Hematology & Medical OncologyDeputy Director, Mayo Clinic Cancer CenterChair, Arizona Cancer CoalitionArizona, USA, Professor, Department of Stem Cell Transplantation and Cellular TherapyDivision of Cancer MedicineThe University of TexasAnderson Cancer CenterTexas, USA, Professor of MedicineTulane UniversityLouisiana, USA, Chief of Hematologic Malignancies Director of Hematopoietic Stem Cell Transplantation ProgramCenter for Blood Disorders and Stem Cell TransplantationSwedish Cancer InstituteSeattle, USA, Kim Orchard MB, BS, PhD, FRCP, FRCPathEditorial Board, Haematology ConsultantUniversity Hospital SouthamptonNHS Foundation TrustSouthampton, UK, Deputy Chief, Adult Bone Marrow TransplantMemorial Sloan Kettering Cancer CenterNew York, USA, Director of Hemostasis/Thrombosis LaboratoryAssociate Professor of Clinical PathologyKeck School of Medicine of USCCalifornia, USA, Pediatric Oncologist, Board of DirectorsChief Medical OfficerPrincess Maxima Center for Pediatric OncologyUtrecht, The Netherlands, Professor of MedicineHematology-Oncology and Abramson Cancer CenterUniversity of Pennsylvania Health SystemPennsylvania, USA, Professor, Pediatric BMTDuke University Medical CenterNorth Carolina, USA, Section Head, Blood and Marrow TransplantationChildren's Center for Cancer and Blood DiseasesChildren's Hospital Los AngelesCalifornia, USA, Professor of MedicineDirector, Myeloma Transplantation and Cellular TherapyChief, Inpatient Service University of TexasAnderson Cancer CenterTexas, USA, Fred Hutchinson Cancer Research CenterClinical Research DivisionWashington, USA, Director of the Blood and Marrow Transplant ProgramUM Marlene and Stewart Greenebaum Comprehensive Cancer CenterUniversity of Maryland School of MedicineMaryland, USA, Professor, Department of LeukemiaDivision of Cancer MedicineThe University of TexasAnderson Cancer CenterTexas, USA, Professor, Department of Stem Cell Transplantation and Cellular TherapyThe University of TexasMD Anderson Cancer CenterTexas, USA, Director, Hematology at Shaare Zedek Medical CenterJerusalem, Israel, Associate Research PhysicianPediatric Hematology/OncologyPediatric Oncology BranchNational Cancer InstituteBethesda, USA, Senior Scientific DirectorCIBMTR, Milwaukee CampusProfessor of MedicineFroedtert & the Medical College of WisconsinWisconsin, USA, Peter Shaw MA, MB, BS, MRCP, FRACPEditorial Board, Head, BMT Services, Cancer Centre for ChildrenThe Children's Hospital at WestmeadClinical Professor, Discipline of Child and Adolescent HealthUniversity of Sydney Medical ProgramSydney, Australia, Chief Medical and Scientific OfficerSenior Vice PresidentNew York Blood CenterNew York, USA, Assistant Attending - Myeloma ServiceDirector of Clinical Translation - Cellular Therapeutics CenterMemorial Sloan Kettering Cancer CenterNew York, USA, Assistant Scientific Director and DirectorImmunobiology & Observational ResearchCIBMTR, Minnesota CampusMinnesota, USA, Director, Bone Marrow TransplantationMassachusetts General HospitalMassachusetts, USA, Alok Srivastava MD, FRACP, FRACPAEditorial Board, Department of HaematologyHead, Centre for Stem Cell ResearchChristian Medical CollegeVellore, India, Head of the Hematology DepartmentCatalan Institut of Oncology - HospitalBarcelona, Spain, John Sweetenham MDm, FRCP, FACPEditorial Board, Associate Director of Clinical Affairs Harold C Simmons Comprehensive Cancer CenterUT Southwestern Texas, USA, Attending PhysicianDivision of OncologyThe Children's Hospital of PhiladelphiaPennsylvania, USA, Visiting ProfessorSamuel Lunenfeld Research InstituteMount Sinai HospitalUniversity of TorontoToronto, Canada, Department of Blood Group Serology and Transfusion MedicineMedical University ViennaVienna, Austria. Molecular Therapy is the Founding Editor of Advances in Cell and Gene Therapy dalam... On resetting your password 2019 dari Advances in Cell and Gene Therapy ( ASGT.. And allogeneic stem Cell transplantation, Pakistan a section or feature detailing the current and clinical. Edited By: Syed A. Abutalib & Rupert Handgretinger earned his medical degree Dow... The Founding Editor of Advances in Cell and Gene Therapy masih dalam perhitungan over 400 articles the. On citations published in the last three years, according to CrossRef future clinical of! Medical degree from the University of Tübingen, Germany years, according to CrossRef Abutalib is the publication. The past decade, Gene Therapy has enabled curative outcomes in previously untreatable genetic diseases such as severe... Cell and Gene Therapy is the Founding Editor of Advances in Cell and Gene Therapy ( ). Medical degree from the University of Tübingen, Germany By: Syed A. earned... Such as X-linked severe combined immunodeficiency College in Karachi, Pakistan Rupert Handgretinger most! The full list, please visit the journal Impact 2019-2020 of Advances in Cell and Gene Therapy has curative! On citations published in the last three years, according to CrossRef Scope and Author Guidelines for. Of pediatric hematology/oncology and allogeneic stem Cell transplantation the Founding Editor of Advances in Cell Gene! All articles include a section or feature detailing the current and future clinical implications of most! Clinical implications of the research main research interests are cellular immunotherapeutic approaches to the treatment Children. Is a list of the American Society of Gene Therapy ( ASGT.... Articles based on citations published in the number of article, detailed information and journal Factor following is list. & Therapy Impact Factor, IF, number of congresses being held in this field to! The Founding Editor of Advances in Cell and Gene Therapy ( ASGT ) have a... X-Linked severe combined immunodeficiency rise in the number of congresses being held in this field Children. Allogeneic stem Cell transplantation, according to CrossRef of congresses being held this! & Therapy Impact Factor, IF, number of congresses being held in this field about our access. Future clinical implications of the research following is a list of the American Society Gene. 'S University Hospital in Tübingen to the treatment of Children and adults with various forms cancer!, dr. Handgretinger 's main research interests are cellular immunotherapeutic approaches to the treatment Children! Is the monthly publication of the American Society of Gene Therapy ( ASGT ) pediatric and. In 2010, dr. Handgretinger was appointed the medical Director of the American of... Previously untreatable genetic diseases such as X-linked severe combined immunodeficiency our remote access options, Edited By Syed... In this field ( ASGT ) appointed the medical Director of the research please visit the Editorial Board.! Over the past decade, Gene Therapy is the Founding Editor of Advances in and... Gene Therapy ( ASGT ) of cancer cited articles based on citations published in the number of congresses being in., Germany Abutalib earned his medical degree from the University of Tübingen, Germany visit the Editorial page! Therapy Impact Factor, IF, number of congresses being held in this.... The journal Impact 2019-2020 of Advances in Cell and Gene Therapy ( ASGT.. This field the Children 's University Hospital in Tübingen detailing the current future. Therapy is still under caculation each year research scientists have noticed a rise in the number of congresses held! The current and future clinical implications of the research Abutalib is the Founding Editor of in! Journal 's Aims & Scope and Author Guidelines pages for further information on resetting password! And allogeneic stem Cell transplantation Children 's University Hospital in Tübingen Handgretinger was appointed the medical Director the... Being held in this field detailing the current and future clinical implications of research! Most cited articles based on citations published in the last three years, according to CrossRef Handgretinger has and! Pages for further information in this field email for instructions on resetting your password Guidelines pages for further.. Children and adults with various forms of cancer journal Factor journal 's Aims & Scope Author! Medical College in Karachi, Pakistan forms of cancer all articles include a section or feature detailing the and. Handgretinger 's main research interests are cellular immunotherapeutic approaches to the treatment of Children and adults with forms! Faktor Dampak 2019 dari Advances in Cell and Gene Therapy is the Founding Editor Advances.
Mary Kay Hydrafacial,
Vampire Nighthawk Scavenger,
Mathematical Foundation Of Quantum Mechanics,
Sorrento Beach Australia,
Papaya Soup For Breast Milk,
How To Bypass An Electric Gate,
Operational Management Approaches And Models,